Actinogen Medical (ASX:ACW) Operating Cash Flow per Share : A$-0.01 (TTM As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Actinogen Medical Operating Cash Flow per Share?

Actinogen Medical's operating cash flow per share for the six months ended in Dec. 2023 was A$-0.00. Actinogen Medical's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.01.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -100.00% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -11.40% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was -2.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Actinogen Medical's Operating Cash Flow per Share or its related term are showing as below:

ASX:ACW' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -100 Med: 7.05 Max: 55.5
Current: -100

During the past 13 years, Actinogen Medical's highest 3-Year average Operating Cash Flow per Share Growth Rate was 55.50% per year. The lowest was -100.00% per year. And the median was 7.05% per year.

ASX:ACW's 3-Year OCF Growth Rate is ranked worse than
96.31% of 1194 companies
in the Biotechnology industry
Industry Median: 3.6 vs ASX:ACW: -100.00

Actinogen Medical Operating Cash Flow per Share Historical Data

The historical data trend for Actinogen Medical's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Actinogen Medical Operating Cash Flow per Share Chart

Actinogen Medical Annual Data

Trend

Jun14

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Operating Cash Flow per Share

Get a 7-Day Free Trial

-0.01

Actinogen Medical Semi-Annual Data
	Jun14	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Operating Cash Flow per Share	Get a 7-Day Free Trial															-	-	-	-	-0.01

Competitive Comparison of Actinogen Medical's Operating Cash Flow per Share

For the Biotechnology subindustry, Actinogen Medical's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Actinogen Medical's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Actinogen Medical's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Actinogen Medical's Price-to-Operating-Cash-Flow falls into.

Actinogen Medical Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Actinogen Medical's Operating Cash Flow per Share for the fiscal year that ended in Jun. 2024 is calculated as

Operating Cash Flow per Share (A: Jun. 2024 )	=	Cash Flow from Operations (A: Jun. 2024 )	/	Shares Outstanding (Diluted Average) (A: Jun. 2024 )
	=	-16.951	/	2174.301
	=	-0.01

Actinogen Medical's Operating Cash Flow per Share for the quarter that ended in Jun. 2024 is calculated as

Operating Cash Flow per Share (Q: Dec. 2023 )	=	Cash Flow from Operations (Q: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
	=	-6.491	/	2092.295
	=	-0.00

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.01

Actinogen Medical Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Actinogen Medical's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Actinogen Medical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actinogen Medical Ltd (ASX:ACW) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

ATGGF:USA 3AC:Germany

Address

109 Pitt Street, Level 9, Suite 901, Sydney, NSW, AUS, 2000

Website

https://www.actinogen.com.au

Actinogen Medical Ltd is a biotechnology company. The company develops drugs for Alzheimer's disease and the cognitive decline associated with other neurological diseases. It is focused on the clinical development of Xanamem, an oral medication for neurological diseases amenable to its mechanism of lowering cortisol in brain cells. Geographically, the company's income is derived in Australia.

Actinogen Medical Headlines

From GuruFocus

Accuride Corporation: Earnings Report For Q2 2014

By Black Iguana Nitish • 10-13-2014

Stocks That Are Making A Good Come Back

By reports.droy reports.droy • 03-10-2015